Literature DB >> 10909934

Health researchers' views of ethics committee functioning in New Zealand.

C Paul1.   

Abstract

AIMS: To find out, from the perspective of researchers, how ethics committees are dealing with matters of ethical concern in research on humans and to seek the views of researchers on their role in thinking through the ethical issues in research.
METHODS: A sample of researchers was selected from the Health Research Council database of grant recipients. Information was sought, using a mailed questionnaire, in relation to essential elements of concern to ethics committees according to the 1996 National Standard, types of study undertaken, codes of practice, national application forms, multicentre review, aspects of committee function and the role of researchers.
RESULTS: The response rate was 35/40 (87.5%). Approximately half the respondents commented favourably on most aspects of ethics committee functioning. Major criticisms were directed at the assessment of risks and benefits, scientific validity and handling of consent procedures. Consistent weaknesses in multicentre review, quality of advice and the composition of committees were noted. Positive aspects were: availability of chairpersons for discussion, the protection of vulnerable participants, the handling of the Health Information Privacy Code and the introduction of a national application form. Most researchers expected to take a major role in thinking through the ethical issues in their work. Half reported occasions where ethics committees had unnecessarily impeded research.
CONCLUSIONS: The high level of commitment of researchers to ethics should be acknowledged by involving them more in guideline development and education. Perceived deficiencies in the range of expertise on ethics committees, particularly expertise to judge potential harms in experimental research, should be further investigated and addressed. Recommendations to improve the quality of ethical review include reducing the overload on committees by identifying categories of research which might not require full ethics committee review.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  2000        PMID: 10909934

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  5 in total

1.  Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?

Authors:  Lorraine E Ferris
Journal:  CMAJ       Date:  2002-05-14       Impact factor: 8.262

2.  Obstacles to researching the researchers: a case study of the ethical challenges of undertaking methodological research investigating the reporting of randomised controlled trials.

Authors:  Joanne E McKenzie; G Peter Herbison; Paul Roth; Charlotte Paul
Journal:  Trials       Date:  2010-03-21       Impact factor: 2.279

3.  Ethical aspects in tissue research: thematic analysis of ethical statements to the research ethics committee.

Authors:  Arja Halkoaho; Anna-Maija Pietilä; Mari Vesalainen; Kirsi Vähäkangas
Journal:  BMC Med Ethics       Date:  2012-08-08       Impact factor: 2.652

4.  International variation in ethics committee requirements: comparisons across five Westernised nations.

Authors:  Felicity Goodyear-Smith; Brenda Lobb; Graham Davies; Israel Nachson; Sheila M Seelau
Journal:  BMC Med Ethics       Date:  2002-04-19       Impact factor: 2.652

5.  Perspectives of Singaporean biomedical researchers and research support staff on actual and ideal IRB review functions and characteristics: A quantitative analysis.

Authors:  Markus K Labude; Liang Shen; Yujia Zhu; G Owen Schaefer; Catherine Ong; Vicki Xafis
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.